Broly F - Search Results

1

Debrisoquine/sparteine hydroxylation genotype and phenotype: analysis of common mutations and alleles of CYP2D6 in a European population.

Broly F, Gaedigk A, Heim M, Eichelbaum M, Morike K, Meyer UA. Broly F, et al. DNA Cell Biol. 1991 Oct;10(8):545-58. doi: 10.1089/dna.1991.10.545. DNA Cell Biol. 1991. PMID: 1681816

2

Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteers.

Graf T, Broly F, Hoffmann F, Probst M, Meyer UA, Howald H. Graf T, et al. Among authors: broly f. Eur J Clin Pharmacol. 1992;43(4):399-403. doi: 10.1007/BF02220616. Eur J Clin Pharmacol. 1992. PMID: 1451720

3

Debrisoquine oxidation polymorphism: phenotypic consequences of a 3-base-pair deletion in exon 5 of the CYP2D6 gene.

Broly F, Meyer UA. Broly F, et al. Pharmacogenetics. 1993 Jun;3(3):123-30. Pharmacogenetics. 1993. PMID: 8101460

4

Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotype.

Tyndale R, Aoyama T, Broly F, Matsunaga T, Inaba T, Kalow W, Gelboin HV, Meyer UA, Gonzalez FJ. Tyndale R, et al. Among authors: broly f. Pharmacogenetics. 1991 Oct;1(1):26-32. doi: 10.1097/00008571-199110000-00005. Pharmacogenetics. 1991. PMID: 1844820

5

Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution.

Marez D, Legrand M, Sabbagh N, Lo Guidice JM, Spire C, Lafitte JJ, Meyer UA, Broly F. Marez D, et al. Among authors: broly f. Pharmacogenetics. 1997 Jun;7(3):193-202. doi: 10.1097/00008571-199706000-00004. Pharmacogenetics. 1997. PMID: 9241659

6

A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency.

Broly F, Marez D, Lo Guidice JM, Sabbagh N, Legrand M, Boone P, Meyer UA. Broly F, et al. Hum Genet. 1995 Nov;96(5):601-3. doi: 10.1007/BF00197419. Hum Genet. 1995. PMID: 8530011

7

An efficient strategy for detection of known and new mutations of the CYP2D6 gene using single strand conformation polymorphism analysis.

Broly F, Marez D, Sabbagh N, Legrand M, Millecamps S, Lo Guidice JM, Boone P, Meyer UA. Broly F, et al. Pharmacogenetics. 1995 Dec;5(6):373-84. doi: 10.1097/00008571-199512000-00006. Pharmacogenetics. 1995. PMID: 8747409

8

Nomenclature for human CYP2D6 alleles.

Daly AK, Brockmöller J, Broly F, Eichelbaum M, Evans WE, Gonzalez FJ, Huang JD, Idle JR, Ingelman-Sundberg M, Ishizaki T, Jacqz-Aigrain E, Meyer UA, Nebert DW, Steen VM, Wolf CR, Zanger UM. Daly AK, et al. Among authors: broly f. Pharmacogenetics. 1996 Jun;6(3):193-201. doi: 10.1097/00008571-199606000-00001. Pharmacogenetics. 1996. PMID: 8807658

9

Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males.

Rothman N, Hayes RB, Bi W, Caporaso N, Broly F, Woosley RL, Yin S, Feng P, You X, Meyer UA. Rothman N, et al. Among authors: broly f. Pharmacogenetics. 1993 Oct;3(5):250-5. doi: 10.1097/00008571-199310000-00004. Pharmacogenetics. 1993. PMID: 8287063

10

N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers.

Hayes RB, Bi W, Rothman N, Broly F, Caporaso N, Feng P, You X, Yin S, Woosley RL, Meyer UA. Hayes RB, et al. Among authors: broly f. Carcinogenesis. 1993 Apr;14(4):675-8. doi: 10.1093/carcin/14.4.675. Carcinogenesis. 1993. PMID: 8472331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters